Literature DB >> 6385650

Ticlopidine: quo vadis? Subarachnoid hemorrhage.

H Ono, M Mizukami, K Kitamura, H Kikuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6385650

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN： 0379-0363


× No keyword cloud information.
  8 in total

Review 1.  Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Nima Etminan; Mervyn D I Vergouwen; Don Ilodigwe; R Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-02       Impact factor: 6.200

Review 2.  Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.

Authors:  D McTavish; D Faulds; K L Goa
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

3.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 4.  Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.

Authors:  E Saltiel; A Ward
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 5.  Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: A review and synthesis.

Authors:  Julian V Clarke; Julia M Suggs; Deepti Diwan; Jin V Lee; Kim Lipsey; Ananth K Vellimana; Gregory J Zipfel
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-28       Impact factor: 6.200

Review 6.  Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.

Authors:  S M Dorhout Mees; W M van den Bergh; A Algra; G J E Rinkel
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 7.  Role of platelets in the pathogenesis of delayed injury after subarachnoid hemorrhage.

Authors:  Ari Dienel; Peeyush Kumar T; Spiros L Blackburn; Devin W McBride
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-10       Impact factor: 6.960

Review 8.  Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis.

Authors:  Thomas Beez; Hans-Jakob Steiger; Nima Etminan
Journal:  BMC Neurol       Date:  2017-12-07       Impact factor: 2.474
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.